# Agent exchanges — D2N030

Questions, patient answers, routing instructions, specialist proposals, and aggregator updates in order.

## 131. Turn 15 — diagnosis and plan

**pipeline → doctor_team** · resumed

Resuming after 15 completed history-taking turns. Saved questions and patient answers are reused.

## 132. Turn 15 — diagnosis and plan

**pipeline → doctor_team** · evidence frozen

Case features frozen. History-taking stop reason: max_turns.

## 133. Turn 15 — diagnosis and plan

**orchestrator → gynaecologist, psychiatrist, surgeon, gynaecology, breast_surgery, breast_surgeon, gynecologist, radiologist, endocrinologist, endocrinology, psychiatry** · routing

Reuse the specialists activated during history taking. Evidence is frozen. Provide preliminary diagnosis, diagnostic discussion and a treatment plan without asking further questions.

## 134. Turn 15 — diagnosis and plan

**specialist:gynaecologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Breast fibroadenoma 2. Cyclical breast pain (mastalgia) 3. Anxiety disorder

diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety around the time of her period and concerns about breast lumps. The lumps are small, movable, and have been present since she had her son, with no significant changes in size or appearance over time. The left breast lump is denser and more tender, with tenderness reminiscent of breastfeeding-related soreness. The anxiety symptoms spike the week before her period and occur randomly afterward, with a history of irritability on progesterone. The absence of changes in the lumps related to the menstrual cycle suggests a benign etiology. The differential diagnoses include breast fibroadenoma, which is a common benign breast lesion in women of reproductive age, especially in those with a history of pregnancy. Cyclical breast pain (mastalgia) is also likely given the temporal relationship with the menstrual cycle and the presence of tenderness. Anxiety disorder is a plausible diagnosis given the reported symptoms and their fluctuation with the menstrual cycle. Other differentials such as fibrocystic breast disease or breast cancer are less likely given the stable nature of the lumps and lack of concerning features like skin changes or nipple discharge.

treatment_plan: 1. Further evaluation: Recommend mammography and ultrasound of the breasts to evaluate the lumps and rule out malignancy. These investigations are indicated due to the presence of palpable breast lumps and the need to exclude breast cancer, especially in a woman of this age. 2. Medication: For cyclical breast pain, consider nonsteroidal anti-inflammatory drugs (NSAIDs) or selective serotonin reuptake inhibitors (SSRIs) if anxiety is prominent. Monitor for side effects and contraindications. 3. Non-drug management and education: Advise the patient to wear a supportive bra, reduce caffeine intake, and manage stress through relaxation techniques. Educate her on the importance of regular breast self-examination and the signs and symptoms of breast cancer that require urgent evaluation. 4. Follow-up: Schedule a follow-up appointment in 2-4 weeks after the imaging results are available. If the imaging is normal and the lumps are confirmed to be benign, reassess the anxiety symptoms and consider referral to a mental health professional if needed.

Suggested follow-up: N/A

## 135. Turn 15 — diagnosis and plan

**specialist:psychiatrist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Premenstrual dysphoric disorder (PMDD) 2. Fibrocystic breast changes (benign breast disease) 3. Anxiety disorder (generalized)

diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety symptoms that correlate with her menstrual cycle, particularly spiking the week before her period. This pattern, along with the presence of breast lumps that are tender and have been present since childbirth, suggests a possible link between her anxiety and hormonal fluctuations. The breast lumps are small, movable, and have not changed significantly in size or appearance, which is consistent with fibrocystic breast changes, a benign condition often associated with cyclical breast tenderness. The patient's history of irritability on progesterone further supports a hormonal component to her symptoms. Differential diagnoses include PMDD, which is a severe form of premenstrual syndrome with significant emotional and physical symptoms, and generalized anxiety disorder, which may coexist with PMDD. Other considerations include thyroid dysfunction or other endocrine disorders, though no prior thyroid function tests or sex hormone evaluations have been reported. The absence of nipple discharge, skin changes, or significant changes in lump characteristics reduces the likelihood of malignancy, but further evaluation is warranted.

treatment_plan: 1. Further evaluation: Recommend breast imaging (mammogram or ultrasound) to evaluate the breast lumps and rule out malignancy. Consider thyroid function tests and sex hormone level evaluations to assess for endocrine-related causes of anxiety and breast changes. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) such as sertraline or fluoxetine, which are effective for premenstrual symptoms. For anxiety, SSRIs or benzodiazepines (short-term use) may be considered. For fibrocystic breast changes, no specific medication is required, but analgesics for breast tenderness may be used. 3. Non-drug management and education: Encourage regular breast self-examinations and monitoring for any changes in the lumps. Recommend lifestyle modifications such as reducing caffeine intake, managing stress, and maintaining a balanced diet. Educate the patient on the benign nature of fibrocystic breast changes and the importance of regular follow-up. 4. Follow-up: Schedule a follow-up appointment in 2-4 weeks to review the results of the breast imaging and thyroid function tests. If symptoms persist or worsen, reassess and consider additional investigations or referrals.

Suggested follow-up: N/A

## 136. Turn 15 — diagnosis and plan

**specialist:surgeon → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Premenstrual dysphoric disorder (PMDD) 3. Differential: Breast cysts

diagnosis_discussion: The patient is a 40-year-old female with a history of anxiety symptoms around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present since she had her son and have not changed much except for possibly getting slightly smaller. The lumps are small, movable, and have not changed significantly in size or appearance over time. The anxiety symptoms spike the week before her period and then occur randomly afterward. The patient has not noticed any changes in the size, tenderness, or consistency of the lumps related to her menstrual cycle. The anxiety symptoms were particularly severe in November and December, with spikes the week before her period and random occurrences afterward, though they have improved recently. The patient also experienced irritability in the past, especially when on progesterone, which was not directly linked to her periods. The physical examination reveals small, movable lumps in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The patient has no prior breast imaging or biopsy reported. The differential diagnoses include fibrocystic breast changes, premenstrual dysphoric disorder (PMDD), and breast cysts. Fibrocystic breast changes are a common benign condition characterized by breast lumps that are often tender and may fluctuate with the menstrual cycle. PMDD is a severe form of premenstrual syndrome that can cause significant anxiety and mood changes. Breast cysts are fluid-filled sacs that can be tender and may be associated with breast discomfort. The absence of changes in the lumps related to the menstrual cycle and the presence of anxiety symptoms that are not directly linked to the lumps support the consideration of PMDD. The lack of prior breast imaging or biopsy makes it difficult to rule out other conditions, but the clinical presentation is more consistent with fibrocystic changes and PMDD.

treatment_plan: 1. Further evaluation: Recommend breast imaging (mammogram or ultrasound) to evaluate the breast lumps and rule out other pathologies. Consider thyroid function tests and sex hormone level evaluations to assess for hormonal imbalances. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) such as sertraline or fluoxetine, which are effective in managing premenstrual symptoms. For breast discomfort, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen may be used. 3. Non-drug management and education: Encourage regular breast self-examinations and monitoring for any changes in the lumps. Recommend a low-fat diet and regular exercise to manage breast discomfort. Advise the patient to manage stress through relaxation techniques and to seek support if anxiety symptoms persist. 4. Follow-up: Schedule a follow-up appointment in one to two weeks to discuss the results of the breast imaging and thyroid function tests. If symptoms persist or worsen, consider a referral to a gynecologist or a breast specialist for further evaluation.

Suggested follow-up: N/A

## 137. Turn 15 — diagnosis and plan

**specialist:gynaecology → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Premenstrual dysphoric disorder (PMDD) 3. Differential: Breast cancer (low suspicion based on stable, movable, non-fixed lumps and no skin changes)

diagnosis_discussion: The patient is a 40-year-old female with a history of anxiety symptoms around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present since she had her son and have not changed significantly in size or appearance over time. The lumps are small, movable, and tender, especially in the left breast, with a history of similar soreness during breastfeeding. The anxiety symptoms spike the week before her period and occur randomly afterward, with a history of irritability on progesterone. The absence of changes in the lumps related to her menstrual cycle and the presence of stable, non-fixed, movable lumps suggest fibrocystic breast changes. The anxiety symptoms are consistent with premenstrual dysphoric disorder (PMDD). Breast cancer is a differential diagnosis, but the stable, non-fixed, movable lumps and absence of skin changes or nipple discharge make it less likely. Other differentials include hormonal fluctuations and thyroid dysfunction, though no prior thyroid function tests or sex hormone level evaluations have been reported.

treatment_plan: 1. Further evaluation: Mammography and ultrasound of the breasts to evaluate the lumps and rule out malignancy. Thyroid function tests and sex hormone level evaluations to assess for hormonal imbalances. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) or low-dose oral contraceptives to regulate menstrual cycles and alleviate symptoms. For fibrocystic breast changes, consider analgesics for pain management. 3. Non-drug management and education: Encourage a low-fat diet, regular exercise, and stress management techniques. Advise the patient to monitor the lumps for any changes in size, shape, or tenderness and to report any new symptoms. 4. Follow-up: Schedule a follow-up appointment in 2-4 weeks after the initial evaluation to review results and adjust treatment as needed. If any concerning findings are identified, further specialist referral or intervention may be required.

Suggested follow-up: N/A

## 138. Turn 15 — diagnosis and plan

**specialist:breast_surgery → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Cyclical breast discomfort 3. Anxiety related to menstrual cycle
diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present for a while, since she had her son, and have not changed much except for possibly getting slightly smaller. The lumps are small, movable, and have not changed significantly in size or appearance over time. The patient's anxiety symptoms spike the week before her period and then occur randomly afterward, though they have improved recently. The lumps are not associated with changes in the menstrual cycle, and the patient has not noticed any changes in the size, tenderness, or consistency of the lumps related to her menstrual cycle. The patient also experienced irritability in the past, especially when on progesterone, which was not directly linked to her periods. The physical examination reveals small, movable lumps in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. There is no prior breast imaging or biopsy reported, and the patient is willing to undergo evaluation if needed. The differential diagnoses include fibrocystic breast changes, cyclical breast discomfort, and anxiety related to the menstrual cycle. Fibrocystic breast changes are considered due to the presence of small, movable lumps and tenderness, which are common in this condition. Cyclical breast discomfort is considered due to the patient's symptoms spiking around the time of her period. Anxiety related to the menstrual cycle is considered due to the patient's reported anxiety symptoms around the time of her period and the improvement in symptoms recently. The absence of nipple discharge, skin changes, and significant changes in the lumps over time makes malignancy less likely at this stage. The lack of prior breast imaging or biopsy means further evaluation is needed to confirm the diagnosis.
treatment_plan: 1. Further evaluation: Recommend mammography and ultrasound of the breasts to evaluate the lumps and rule out malignancy. This is indicated due to the presence of breast lumps and the need to confirm the diagnosis. 2. Medication: Consider over-the-counter analgesics such as ibuprofen for breast tenderness. If anxiety symptoms are significant, consider referral to a mental health professional for evaluation and possible treatment with anxiolytics or antidepressants. 3. Non-drug management and education: Advise the patient to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management techniques. Educate the patient on the importance of regular breast self-examinations and the signs and symptoms of breast cancer, such as changes in the size or shape of the breast, nipple discharge, or skin changes. 4. Follow-up: Schedule a follow-up appointment in one to two weeks to discuss the results of the imaging studies and to monitor the patient's symptoms. If the patient's anxiety symptoms persist or worsen, consider a referral to a mental health professional for further evaluation and treatment.

Suggested follow-up: N/A

## 139. Turn 15 — diagnosis and plan

**specialist:breast_surgeon → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Cyclical breast discomfort 3. Anxiety related to menstrual cycle
diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present since she had her son and have not changed much except for possibly getting slightly smaller. The lumps are small, movable, and have not changed significantly in size or appearance over time. The patient reports that the lumps are tender, especially in the left breast, and she recalls experiencing similar soreness during breastfeeding. The anxiety symptoms spike the week before her period and then occur randomly afterward. The patient has not noticed any changes in the size, tenderness, or consistency of the lumps related to her menstrual cycle. The anxiety symptoms were particularly severe in November and December, with spikes the week before her period and random occurrences afterward, though they have improved recently. The patient also experienced irritability in the past, especially when on progesterone, which was not directly linked to her periods. The physical examination reveals small, movable lumps in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The patient has no prior breast imaging or biopsy reported. The differential diagnoses include fibrocystic breast changes, cyclical breast discomfort, and anxiety related to the menstrual cycle. Fibrocystic breast changes are considered due to the presence of small, movable lumps, tenderness, and the patient's history of similar symptoms during breastfeeding. Cyclical breast discomfort is considered due to the correlation of symptoms with the menstrual cycle. Anxiety related to the menstrual cycle is considered due to the patient's reported anxiety symptoms spiking the week before her period and occurring randomly afterward. The patient has no prior thyroid function tests or sex hormone level evaluations reported, which may be relevant to her symptoms.
treatment_plan: 1. Further evaluation: Recommend breast imaging (mammogram or ultrasound) to evaluate the breast lumps and rule out other pathologies. This is indicated due to the presence of breast lumps and the need to differentiate between benign and malignant lesions. 2. Medication: Consider over-the-counter analgesics such as acetaminophen or ibuprofen for breast tenderness. If anxiety symptoms are significant, consider referral to a mental health professional for evaluation and management. 3. Non-drug management and education: Advise the patient to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management techniques. Educate the patient about the normal variations in breast tissue and the importance of regular breast self-examinations. Encourage the patient to monitor her symptoms and report any changes. 4. Follow-up: Schedule a follow-up appointment in 2-4 weeks to review the results of the breast imaging and assess the patient's symptoms. If the patient's anxiety symptoms persist or worsen, consider a referral to a mental health professional for further evaluation and management.

Suggested follow-up: N/A

## 140. Turn 15 — diagnosis and plan

**specialist:gynecologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Breast fibroadenoma 2. Cyclical breast pain (mastalgia) 3. Anxiety related to menstrual cycle

diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety around the time of her period and concerns about breast lumps. The lumps have been present for a while, since she had her son, and have not changed much except for possibly getting slightly smaller. They are small, movable, and tender, especially in the left breast, with a history of similar soreness during breastfeeding. The anxiety symptoms spike the week before her period and then occur randomly afterward, though they have improved recently. The patient has no prior breast imaging or biopsy, and no history of progesterone use. The physical examination reveals small, movable lumps in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The differential diagnoses include breast fibroadenoma, which is a common benign breast tumor, especially in younger women, and is typically movable and non-tender. Cyclical breast pain (mastalgia) is also a consideration, as it is often related to hormonal changes during the menstrual cycle. Anxiety related to the menstrual cycle is another possible diagnosis, given the timing of her symptoms. Other differentials such as breast cysts or fibrocystic changes are less likely given the description of the lumps as small and not changing significantly with the menstrual cycle. The absence of nipple discharge or skin changes makes malignancy less likely, though further evaluation is needed to confirm.

treatment_plan: 1. Further evaluation: Recommend a breast ultrasound to evaluate the lumps and determine their nature. This is indicated to differentiate between solid and cystic lesions and to assess for any suspicious features. 2. Medication: For cyclical breast pain, consider over-the-counter analgesics such as ibuprofen or acetaminophen. If symptoms are severe, a low-dose oral contraceptive may be considered to regulate hormonal fluctuations, though this should be discussed with the patient given her history of anxiety. 3. Non-drug management and education: Advise the patient to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management techniques such as mindfulness or yoga. Encourage her to monitor her symptoms and note any changes in the lumps or her anxiety symptoms. 4. Follow-up: Schedule a follow-up appointment in two weeks to discuss the results of the breast ultrasound and to reassess her symptoms. If the ultrasound is inconclusive or if there are any concerning findings, a referral to a breast specialist for further evaluation may be necessary.

Suggested follow-up: N/A

## 141. Turn 15 — diagnosis and plan

**specialist:radiologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Premenstrual dysphoric disorder (PMDD) 3. Differential: Breast cysts

diagnosis_discussion: The patient is a 40-year-old female with a history of anxiety symptoms around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present since she had her son and have not changed significantly in size or appearance over time. The lumps are small, movable, and have not changed significantly in size or appearance over time. The anxiety symptoms spike the week before her period and then occur randomly afterward, with a history of irritability on progesterone. The physical examination reveals small, movable lumps in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The differential diagnoses include fibrocystic breast changes, premenstrual dysphoric disorder (PMDD), and breast cysts. Fibrocystic breast changes are supported by the presence of small, movable lumps that are tender, especially in the left breast, and have not changed significantly in size or appearance over time. PMDD is supported by the anxiety symptoms that spike the week before her period and then occur randomly afterward, with a history of irritability on progesterone. Breast cysts are considered as a differential diagnosis due to the presence of small, movable lumps in both breasts, with the left one being denser and more tender. The absence of prior breast imaging or biopsy, and the lack of changes in the size, tenderness, or consistency of the lumps related to her menstrual cycle, make it less likely to be a malignant lesion. The patient's history of irritability on progesterone and the absence of prior thyroid function tests or sex hormone level evaluations may also contribute to her symptoms.

treatment_plan: 1. Further evaluation: Mammography and ultrasound of the breasts to evaluate the lumps and rule out malignancy. Thyroid function tests and sex hormone level evaluations to assess for hormonal imbalances. 2. Medication: Consider selective serotonin reuptake inhibitors (SSRIs) for PMDD if symptoms are severe and interfere with daily functioning. Nonsteroidal anti-inflammatory drugs (NSAIDs) for breast tenderness. 3. Non-drug management and education: Encourage regular breast self-examination and monitoring for any changes in the lumps. Recommend a low-fat diet and regular exercise to manage symptoms. Educate on the importance of stress management and relaxation techniques to alleviate anxiety symptoms. 4. Follow-up: Reassessment in one to two weeks after starting any new medications or interventions. If symptoms persist or worsen, further evaluation may be necessary.

Suggested follow-up: N/A

## 142. Turn 15 — diagnosis and plan

**specialist:endocrinologist → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Premenstrual dysphoric disorder (PMDD) 3. Differential: Breast cancer (low suspicion based on stable, movable, non-fixed lumps and no skin changes)

diagnosis_discussion: The patient is a 40-year-old female with a history of anxiety symptoms around the time of her period and concerns about breast lumps. The lumps are present in both breasts, with the left one being denser and more tender. They have been present since she had her son and have not changed significantly in size or appearance over time. The lumps are small, movable, and have not changed significantly in size or appearance over time. The anxiety symptoms spike the week before her period and then occur randomly afterward, with a history of irritability on progesterone. The absence of changes in the lumps related to her menstrual cycle and the presence of stable, movable lumps suggest fibrocystic breast changes. The anxiety symptoms are consistent with premenstrual dysphoric disorder (PMDD). Breast cancer is a differential diagnosis, but the stable, movable nature of the lumps and absence of skin changes or nipple discharge make it less likely. Other differentials include hormonal fluctuations and thyroid dysfunction, though no prior thyroid function tests or sex hormone level evaluations have been reported.

treatment_plan: 1. Further evaluation: Mammogram or ultrasound of the breasts to evaluate the lumps and rule out malignancy. Thyroid function tests and sex hormone level evaluations to assess for hormonal imbalances. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) or low-dose oral contraceptives if appropriate. For fibrocystic breast changes, no specific medication is required, but analgesics may be used for pain relief. 3. Non-drug management and education: Encourage a low-fat diet, regular exercise, and stress management techniques. Advise the patient to monitor the lumps for any changes in size, shape, or tenderness. Educate on the importance of regular breast self-examinations and the signs and symptoms of breast cancer. 4. Follow-up: Schedule a follow-up appointment in 2-4 weeks to review the results of the mammogram or ultrasound and thyroid function tests. If no abnormalities are found, reassess in 6 months or as needed based on symptoms.

Suggested follow-up: N/A

## 143. Turn 15 — diagnosis and plan

**specialist:endocrinology → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Fibrocystic breast changes 2. Premenstrual dysphoric disorder (PMDD) 3. Differential: Breast cancer (low suspicion given stable, non-fixed, movable lumps and no skin changes)

diagnosis_discussion: The 40-year-old female presents with anxiety symptoms around her menstrual cycle and concerns about breast lumps. The lumps are small, movable, and have been present since childbirth, with no significant changes in size or appearance. The left breast is denser and more tender, with tenderness reminiscent of breastfeeding. The anxiety symptoms are cyclical, peaking the week before her period, and have been associated with irritability, particularly when on progesterone. These findings are consistent with fibrocystic breast changes, a common benign condition characterized by cyclic breast pain and palpable lumps, often exacerbated by hormonal fluctuations. The anxiety symptoms align with premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome that includes mood symptoms such as anxiety and irritability. Breast cancer is a differential diagnosis, but the stable, non-fixed, movable nature of the lumps and absence of skin changes or nipple discharge reduce its likelihood. The lack of prior breast imaging or hormone evaluations limits definitive exclusion of other endocrine-related conditions.

treatment_plan: 1. Further evaluation: Recommend mammography and ultrasound of the breasts to evaluate the lumps and rule out malignancy. Consider thyroid function tests and sex hormone level evaluations to assess for endocrine-related causes of anxiety and breast changes. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) such as sertraline or fluoxetine, which are effective for premenstrual mood symptoms. For breast tenderness, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen may be used. 3. Non-drug management and education: Advise a low-fat diet, regular exercise, and stress management techniques such as mindfulness or cognitive-behavioral therapy. Recommend avoiding caffeine and alcohol, which may exacerbate breast tenderness and anxiety. Educate on the importance of regular breast self-examinations and prompt reporting of any new or changing symptoms. 4. Follow-up: Schedule a follow-up in 2-4 weeks after initiating treatment to assess response. Repeat breast imaging if symptoms persist or change. Consider referral to a gynecologist or endocrinologist for further evaluation if symptoms remain unexplained or if hormone-related concerns persist.

Suggested follow-up: N/A

## 144. Turn 15 — diagnosis and plan

**specialist:psychiatry → aggregator** · specialist proposal

Proposed record changes:

preliminary_diagnosis: 1. Premenstrual dysphoric disorder (PMDD) 2. Fibrocystic breast changes (benign breast disease) 3. Anxiety disorder (generalized)

diagnosis_discussion: The patient is a 40-year-old female presenting with anxiety symptoms that correlate with her menstrual cycle, particularly spiking the week before her period. These symptoms have been severe in the past, especially in November and December, though they have improved recently. She also reports concerns about breast lumps, which are small, movable, and have been present since she had her son. The lumps are tender, especially in the left breast, and she recalls similar soreness during breastfeeding. The lumps have not changed significantly in size or appearance over time. The patient has a history of irritability when on progesterone, though this was not directly linked to her periods. There is no prior breast imaging or biopsy reported, and no prior thyroid function tests or sex hormone level evaluations. On physical examination, small, movable lumps are present in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The patient is willing to undergo evaluation if needed.

Differential diagnoses include: 1. Premenstrual dysphoric disorder (PMDD) due to the cyclical nature of the anxiety symptoms and their correlation with the menstrual cycle. 2. Fibrocystic breast changes (benign breast disease) due to the presence of small, movable lumps that are tender and have been present for a while. 3. Anxiety disorder (generalized) due to the presence of anxiety symptoms that occur randomly after her period and have been severe in the past.

treatment_plan: 1. Further evaluation: Breast imaging (mammogram or ultrasound) to evaluate the breast lumps and rule out any malignancy. Thyroid function tests and sex hormone level evaluations to assess for any hormonal imbalances that may be contributing to her symptoms. 2. Medication: For PMDD, selective serotonin reuptake inhibitors (SSRIs) such as sertraline or fluoxetine may be considered. For fibrocystic breast changes, no specific medication is required, but analgesics such as ibuprofen may be used for pain relief. For anxiety disorder, SSRIs or benzodiazepines may be considered, though benzodiazepines should be used cautiously due to the risk of dependence. 3. Non-drug management and education: Encourage the patient to maintain a healthy lifestyle, including regular exercise, a balanced diet, and adequate sleep. She should also be educated on the importance of regular breast self-examinations and the signs and symptoms of breast cancer. She should be advised to monitor her anxiety symptoms and seek medical attention if they worsen. 4. Follow-up: The patient should be followed up in one to two weeks to review the results of the breast imaging and thyroid function tests. If the results are normal, she should be reassessed in one month to monitor her symptoms and adjust treatment as needed.

Suggested follow-up: N/A

## 145. Turn 15 — diagnosis and plan

**aggregator → soap_note** · diagnosis and plan

**Preliminary diagnosis:**

1. Fibrocystic breast changes
2. Premenstrual dysphoric disorder (PMDD)
3. Anxiety disorder (generalized)

**Diagnostic discussion:**

The 40-year-old female presents with anxiety symptoms that correlate with her menstrual cycle, particularly spiking the week before her period. These symptoms have been severe in the past, especially in November and December, though they have improved recently. She also reports concerns about breast lumps, which are small, movable, and have been present since she had her son. The lumps are tender, especially in the left breast, and she recalls similar soreness during breastfeeding. The lumps have not changed significantly in size or appearance over time. The patient has a history of irritability when on progesterone, though this was not directly linked to her periods. There is no prior breast imaging or biopsy reported, and no prior thyroid function tests or sex hormone level evaluations. On physical examination, small, movable lumps are present in both breasts, with the left one being denser and more tender. No nipple discharge or skin changes are observed. The patient is willing to undergo evaluation if needed. The differential diagnoses include fibrocystic breast changes, a common benign condition characterized by cyclic breast pain and palpable lumps, often exacerbated by hormonal fluctuations. Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome that includes mood symptoms such as anxiety and irritability. Anxiety disorder (generalized) may coexist with PMDD. Breast cancer is a differential diagnosis, but the stable, non-fixed, movable nature of the lumps and absence of skin changes or nipple discharge make it less likely.

**Proposed plan:**

1. Further evaluation: Recommend breast imaging (mammogram or ultrasound) to evaluate the breast lumps and rule out malignancy. Consider thyroid function tests and sex hormone level evaluations to assess for hormonal imbalances. 2. Medication: For PMDD, consider selective serotonin reuptake inhibitors (SSRIs) such as sertraline or fluoxetine, which are effective for premenstrual symptoms. For breast pain, consider analgesics such as ibuprofen or acetaminophen. For anxiety, SSRIs or benzodiazepines may be considered, though the latter should be used cautiously due to potential dependency. 3. Non-drug management and education: Advise the patient to maintain a healthy lifestyle, including regular exercise, a balanced diet, and stress management techniques. Recommend limiting caffeine and alcohol intake, as these can exacerbate breast pain and anxiety. Educate the patient on the importance of regular breast self-examinations and the signs of breast cancer (e.g., changes in size, shape, or skin texture, nipple discharge). Encourage the patient to monitor her symptoms and report any changes. 4. Follow-up: Schedule a follow-up appointment in one to two weeks to review the results of the breast imaging and thyroid function tests. If the patient's symptoms persist or worsen, consider a referral to a breast specialist or psychiatrist for further evaluation and management.

